Skip to main content

Advertisement

SpringerLink
Log in

Low-density lipoprotein apheresis for PLA2R-related membranous glomerulonephritis accompanied by IgG4-related tubulointerstitial nephritis

  • Case Report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

IgG4-related disease preferentially involves the kidney by tubulointerstitial nephritis with IgG4-positive plasma cell filtration and/or membranous glomerulonephritis. We reported the case of a 68-year-old man with IgG4-related tubulointerstitial nephritis combined with antiphospholipase A2 receptor (PLA2R)-related membranous glomerulonephritis, in which distinguishing between idiopathic PLA2R-related and IgG4-related secondary membranous glomerulonephritis was difficult. We diagnosed him as having IgG4-related disease, based on a serum IgG4 level of 170 mg/dL and the presence of IgG4-related parotiditis. On renal biopsy, there was tubulointerstitial nephritis with IgG4-positive plasma cell filtration, which was compatible with IgG4-related disease and membranous glomerulonephritis, with concomitant positive staining for PLA2R on immunofluorescence microscopy. The renal function immediately recovered after steroid treatment, probably because of the improvement in the tubulointerstitial lesions, but his nephrotic syndrome was steroid-resistant. Low-density lipoprotein (LDL) apheresis therapy was effective for membranous glomerulonephritis and increased his serum albumin from 1.4 to 2.8 g/dL. Although IgG4-related kidney disease usually accompanies secondary membranous glomerulonephritis, the positive PLA2R staining suggested a concomitant primary membranous glomerulonephritis. The recent treatment strategy, including LDL apheresis, for primary and secondary membranous glomerulonephritis was discussed briefly in this report.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kawano M, Saeki T, Nakashima H, Nishi S, Yamaguchi Y, Hisano S, Yamanaka N, Inoue D, Yamamoto M, Takahashi H, Nomura H, Taguchi T, Umehara H, Makino H, Saito T. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15:615–26.

    Article  PubMed  Google Scholar 

  2. Yamada K, Yamamoto M, Saeki T, Mizushima I, Matsui S, Fujisawa Y, Hara S, Takahashi H, Nomura H, Kawa S, Kawano M. New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases. Arthritis Res Ther. 2017;19:262.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Kawano M, Saeki T, Nakashima H. IgG4-related kidney disease and retroperitoneal fibrosis: an update. Mod Rheumatol. 2019;29:231–9.

    Article  CAS  PubMed  Google Scholar 

  4. Saeki T, Imai N, Ito T, Yamazaki H, Nishi S. Membranous nephropathy associated with IgG4-related systemic disease and without autoimmune pancreatitis. Clin Nephrol. 2009;71:173–8.

    Article  CAS  PubMed  Google Scholar 

  5. Stone JH. IgG4: a tantalizing link between causes of membranous glomerulonephritis and systemic disease. Kidney Int. 2013;83:348–50.

    Article  CAS  PubMed  Google Scholar 

  6. Alexander MP, Larsen CP, Gibson IW, Nasr SH, Sethi S, Fidler ME, Raissian Y, Takahashi N, Chari S, Smyrk TC, Cornell LD. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int. 2013;83:455–62.

    Article  CAS  PubMed  Google Scholar 

  7. Larsen CP, Messias NC, Silva FG, Messias E, Walker PD. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol. 2013;26:709–15.

    Article  CAS  PubMed  Google Scholar 

  8. Zheng K, Teng F, Li XM. Immunoglobulin G4-related kidney disease: Pathogenesis, diagnosis, and treatment. Chronic Dis Transl Med. 2017;3:138–47.

    PubMed  PubMed Central  Google Scholar 

  9. Saeki T, Kawano M, Mizushima I, Yamamoto M, Wada Y, Ubara Y, Nakashima H, Ito T, Yamazaki H, Narita I, Saito T. Recovery of renal function after glucocorticoid therapy for IgG4-related kidney disease with renal dysfunction. Clin Exp Nephrol. 2016;20:87–93.

    Article  CAS  PubMed  Google Scholar 

  10. Quattrocchio G, Barreca A, Demarchi A, Solfietti L, Beltrame G, Fenoglio R, Ferro M, Mesiano P, Murgia S, Del Vecchio G, Massara C, Rollino C, Roccatello D. IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy. Oncotarget. 2018;9:21337–47.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Fervenza FC, Downer G, Beck LH, Sethi S. IgG4-related tubulointerstitial nephritis with membranous nephropathy. Am J Kidney Dis. 2011;58:320–4.

    Article  CAS  PubMed  Google Scholar 

  12. Cravedi P, Abbate M, Gagliardini E, Galbusera M, Buelli S, Sabadini E, Marasà M, Beck LH Jr, Salant DJ, Benigni A, D'Agati V, Remuzzi G. Membranous nephropathy associated with IgG4-related disease. Am J Kidney Dis. 2011;58:272–5.

    Article  CAS  PubMed  Google Scholar 

  13. Jindal N, Yadav D, Passero C, Krasinskas A, Craig F, Bastacky S, Liang KV. Membranous nephropathy: a rare renal manifestation of IgG4-related systemic disease. Clin Nephrol. 2012;77:321–8.

    Article  CAS  PubMed  Google Scholar 

  14. Wada Y, Saeki T, Yoshita K, Ayalon R, Kamimura K, Nakano M, Narita I. Development of IgG4-related disease in a patient diagnosed with idiopathic membranous nephropathy. Clin Kidney J. 2013;6:486–90.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Kanda H, Koya J, Uozaki H, Tateishi S, Sato K, Hagino N, Sawada T, Yamamoto K. Membranous nephropathy with repeated flares in IgG4-related disease. Clin Kidney J. 2013;6:204–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Li XL, Yan TK, Li HF, Xu PC, Jia JY, Wei L, Shang WY, Lin S. IgG4-related membranous nephropathy with high blood and low urine IgG4/IgG ratio: a case report and review of the literature. Clin Rheumatol. 2014;33:145–8.

    Article  CAS  PubMed  Google Scholar 

  17. Sueta S, Kondo M, Matsubara T, Yasuhara Y, Akiyama S, Imai E, Amaike H, Tagawa M. Membranous nephropathy associated with type 1 autoimmune pancreatitis and dominant glomerular IgG4 deposit. CEN Case Rep. 2014;3:18–23.

    Article  PubMed  Google Scholar 

  18. Omokawa A, Komatsuda A, Hirokawa M, Wakui H. Membranous nephropathy with monoclonal IgG4 deposits and associated IgG4-related lung disease. Clin Kidney J. 2014;7:475–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Miyata KN, Kihira H, Haneda M, Nishio Y. IgG4-Related Tubulointerstitial Nephritis Associated with Membranous Nephropathy in Two Patients: Remission after Administering a Combination of Steroid and Mizoribine. Case Rep Nephrol. 2014;2014:678538.

    PubMed  PubMed Central  Google Scholar 

  20. Kurien AA, Raychaudhury A, Walker PD. Membranous nephropathy as a rare renal manifestation of IgG4-related disease. Indian J Nephrol. 2015;25:164–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Stylianou K, Maragkaki E, Tzanakakis M, Stratakis S, Gakiopoulou H, Daphnis E. Acute Interstitial Nephritis and Membranous Nephropathy in the Context of IgG4-Related Disease. Case Rep Nephrol Dial. 2015;5:44–8.

    Article  PubMed  Google Scholar 

  22. Horita S, Fujii H, Mizushima I, Fujisawa Y, Hara S, Yamada K, Inoue D, Nakajima K, Harada K, Kawano M. A case of IgG4-related tubulointerstitial nephritis and membranous glomerulonephritis during the clinical course of gastric cancer: Imaging features of IgG4-related kidney disease. Mod Rheumatol. 2019;29:542–6.

    Article  PubMed  Google Scholar 

  23. Acevedo Ribó M, Ahijado Hormigos FJ, Díaz F, Romero Molina M, Fernandez Rojo MA, Garcia Rubiales MA, García DE. IgG4-related disease and idiopathic membranous nephropathy: "The clothes do not make the man". Clin Nephrol. 2016;86:345–8.

    Article  PubMed  Google Scholar 

  24. Huart J, Grosch S, Bovy C, Moutschen M, Krzesinski JM. IgG4-related membranous glomerulonephritis and generalized lymphadenopathy without pancreatitis: a case report. BMC Nephrol. 2017;18:139.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Zhang W, Glaze JH, Wynne D. Combined membranous nephropathy and tubulointerstitial nephritis as a rare renal manifestation of IgG4-related disease: a case-based literature review. CEN Case Rep. 2018;7:137–42.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Arai H, Toda N, Kamimatsuse R, Nishioka K, Endo S, Akiyama S, Maruyama S, Matsubara T, Yokoi H, Yanagita M. A refractory case of secondary membranous nephropathy concurrent with IgG4-related tubulointerstitial nephritis. Intern Med. 2018;57:2873–7.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Muhsin SA, Masia R, Smith RN, Wallace ZS, Perugino CA, Stone JH, Niles JL, Cortazar FB. Phospholipase A2 receptor-associated membranous nephropathy in a patient with IgG4-related disease: a case report. Medicine (Baltimore). 2019;98(20):e15616.

    Article  CAS  Google Scholar 

  28. Muso E. Beneficial effect of LDL-apheresis in refractory nephrotic syndrome. Clin Exp Nephrol. 2014;18:286–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Muso E, Mune M, Hirano T, Hattori M, Kimura K, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Yuzawa Y, Takemura T, Sugiyama S, Nishizawa Y, Ogahara S, Yorioka N, Sakai S, Ogura Y, Yukawa S, Iino Y, Imai E, Matsuo S, Saito T. Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study. Clin Exp Nephrol. 2015;19:379–86.

    Article  CAS  PubMed  Google Scholar 

  30. Tojo K, Sakai S, Miyahara T. Possible therapeutic application of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS). Nihon Jinzo Gakkai Shi. 1988;30:1153–60.

    CAS  PubMed  Google Scholar 

  31. Muso E, Yashiro M, Matsushima M, Yoshida H, Sawanishi K, Sasayama S. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis? Nephrol Dial Transplant. 1994;9:257–64.

    CAS  PubMed  Google Scholar 

  32. Ideura T, Hora K, Kaneko Y, Yamazaki T, Tokunaga S, Shigematsu H, Kiyosawa K. Effect of low-density lipoprotein-apheresis on nephrotic syndrome due to membranous nephropathy in renal allograft: a case report. Transplant Proc. 2000;32:223–6.

    Article  CAS  PubMed  Google Scholar 

  33. Sato Y, Tsunoda S, Nozue T, Pan Q, Wakasugi H, Yoshimura A. Low-density lipoprotein apheresis therapy for steroid- and cyclosporine-resistant idiopathic membranous nephropathy. Intern Med. 2012;51:2597–602.

    Article  CAS  PubMed  Google Scholar 

  34. Yabuuchi J, Suwabe T, Mizuno H, Ueno T, Hoshino J, Sekine A, Kawada M, Yamanouchi M, Hayami N, Hiramatsu R, Hasegawa E, Sawa N, Takaichi K, Fujii T, Ohashi K, Ubara Y. Long-term low-density lipoprotein apheresis in a patient with refractory idiopathic membranous glomerulonephritis. Intern Med. 2017;56:1543–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Szymanski JM, Waldman M, Conry-Cantilena C, West KA. Treatment-resistant PLA2R-negative membranous nephropathy responsive to low-density lipoprotein apheresis. J Clin Apher. 2019;34:495–8.

    PubMed  Google Scholar 

  36. Koshi-Ito E, Koike K, Tanaka A, Watanabe Y, Kamegai N, Shimogushi H, Shinjo H, Otsuka Y, Inaguma D, Takeda A. Effect of low-density lipoprotein apheresis for nephrotic idiopathic membranous nephropathy as initial induction therapy. Ther Apher Dial. 2019;23:575–83.

    Article  CAS  PubMed  Google Scholar 

  37. Daimon S, Saga T, Nakayama M, Nomura Y, Chikaki H, Dan K, Koni I. Dextran sulphate cellulose columns for the treatment of nephrotic syndrome due to inactive lupus nephritis. Nephrol Dial Transplant. 2000;15:235–8.

    Article  CAS  PubMed  Google Scholar 

  38. Kobayashi S. LDL-Apheresis for diabetic nephropathy: a possible new tool. Nephron. 1998;79:505–6.

    Article  CAS  PubMed  Google Scholar 

  39. Tanaka A, Nakamura T, Sato E, Node K. Impact of low-density lipoprotein apheresis for nephrotic syndrome in a patient with immunoglobulin M nephropathy. Nephrology (Carlton). 2016;21:1073–4.

    Article  Google Scholar 

  40. Ito Y, Inoue T, Okada H. Successful treatment of C1q nephropathy by low-density lipoprotein apheresis. Ther Apher Dial. 2016;20:530–1.

    Article  CAS  PubMed  Google Scholar 

  41. Nakamura T, Kawagoe Y, Matsuda T, Ueda Y, Koide H. Low-density lipoprotein apheresis in a patient with arteriosclerosis obliterans and light chain deposition disease. Clin Nephrol. 2004;61:429–33.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Tokyo Women’s Medical University Medical Center East, 2-1-10, Nishiogu, Arakawa, Tokyo, 116-8567, Japan

    Yoko Nishizawa, Yumi Aoyama, Yumi Hosoda, Tomomi Tamura, Ai Horimoto, Kiyotsugu Omae, Chieko Higuchi, Hiroshi Sakura & Tetsuya Ogawa

  2. Department of Anatomy, Showa University School of Medicine, 1-5-8, Hatanodai, Shinagawa, Tokyo, 142-8555, Japan

    Kazuho Honda

  3. Department of Nephrology, Tokyo Women’s Medical University, 8-1, Kawadacho, Shinjyuku, Tokyo, 162-8666, Japan

    Kosaku Nitta

Authors
  1. Yoko Nishizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kazuho Honda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yumi Aoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yumi Hosoda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tomomi Tamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ai Horimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kiyotsugu Omae
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chieko Higuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hiroshi Sakura
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kosaku Nitta
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Tetsuya Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoko Nishizawa.

Ethics declarations

Conflict of interest

The authors have declared that no conflict of interest exists.

Human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nishizawa, Y., Honda, K., Aoyama, Y. et al. Low-density lipoprotein apheresis for PLA2R-related membranous glomerulonephritis accompanied by IgG4-related tubulointerstitial nephritis. CEN Case Rep 9, 395–403 (2020). https://doi.org/10.1007/s13730-020-00494-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-020-00494-6

Keywords

Search

Navigation